Log in

NASDAQ:RELV - Reliv International Stock Price, Forecast & News

+0.23 (+6.87 %)
(As of 02/21/2020 02:31 AM ET)
Today's Range
Now: $3.58
50-Day Range
MA: $3.81
52-Week Range
Now: $3.58
Volume4,800 shs
Average Volume53,706 shs
Market Capitalization$6.25 million
P/E RatioN/A
Dividend YieldN/A
Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
SectorConsumer Staples
Current SymbolNASDAQ:RELV



Sales & Book Value

Annual Sales$36.12 million
Book Value$6.50 per share


Net Income$-1,900,000.00


Market Cap$6.25 million
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

Reliv International (NASDAQ:RELV) Frequently Asked Questions

What is Reliv International's stock symbol?

Reliv International trades on the NASDAQ under the ticker symbol "RELV."

How were Reliv International's earnings last quarter?

Reliv International, Inc (NASDAQ:RELV) released its quarterly earnings results on Friday, August, 9th. The company reported ($0.22) EPS for the quarter. The firm earned $8.26 million during the quarter. Reliv International had a negative net margin of 0.21% and a negative return on equity of 0.63%. View Reliv International's Earnings History.

When is Reliv International's next earnings date?

Reliv International is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Reliv International.

Has Reliv International been receiving favorable news coverage?

Headlines about RELV stock have trended somewhat positive this week, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Reliv International earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Reliv International.

Are investors shorting Reliv International?

Reliv International saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 3,800 shares, an increase of 137.5% from the January 15th total of 1,600 shares. Based on an average daily trading volume, of 27,700 shares, the short-interest ratio is currently 0.1 days. Currently, 0.3% of the shares of the stock are short sold. View Reliv International's Current Options Chain.

Who are some of Reliv International's key competitors?

What other stocks do shareholders of Reliv International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv International investors own include NovaBay Pharmaceuticals (NBY), RadNet (RDNT), VIVUS (VVUS), Rite Aid (RAD), Acer Therapeutics (ACER), Aquestive Therapeutics (AQST), Catalyst Biosciences (CBIO), Cerus (CERS), Celsion (CLSN) and Conatus Pharmaceuticals (CNAT).

Who are Reliv International's key executives?

Reliv International's management team includes the folowing people:
  • Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
  • Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
  • Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
  • Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
  • Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)

How do I buy shares of Reliv International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Reliv International's stock price today?

One share of RELV stock can currently be purchased for approximately $3.58.

How big of a company is Reliv International?

Reliv International has a market capitalization of $6.25 million and generates $36.12 million in revenue each year. Reliv International employs 156 workers across the globe.View Additional Information About Reliv International.

What is Reliv International's official website?

The official website for Reliv International is http://www.reliv.com/.

How can I contact Reliv International?

Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]

MarketBeat Community Rating for Reliv International (NASDAQ RELV)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  190
MarketBeat's community ratings are surveys of what our community members think about Reliv International and other stocks. Vote "Outperform" if you believe RELV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RELV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel